Purpose: The aim of the study was to update the information about anticoagulant/antiaggregant drugs for ophthalmologists. Materials and methods: A questionnaire investigating the information about anticoagulant/antiaggregant drugs and perioperative management of these agents was answered by 106 ophthalmologists. Results: The participants included residents by 19 (17.9%), specialists by 69 (65.1%), academic members by 18 (17%); 47.2% of the participants have been serving in ophthalmology field for ≥10 years. It was detected that 58 (54.7%) participants were trained about these drugs; and 78 (73.5%) participants have knowledge on terms as well as differentiation of anticoagulant/antiaggregant agents. There was not any difference between the physicians in terms of training and drug differentiation (p=0.970, p=0.948, respectively). Six or more preparations were known by 10.4% of the participants whereas 4 to 6 preparations were known by 48.1% of the participants and 1 to 3 preparations were known by 41.5% of the participants. In consideration of perioperative drug management, it was determined that 52 (49.1%) physicians recommend discontinuation of the medications whereas 24 (22.6%) physicians suggest continuation of drug use. The rates for drug discontinuation were found higher in university hospitals as well as training and research hospitals when compared with public hospitals and private hospitals (p=0.03). Conclusion: Information on anticoagulant/antiaggregant agents as well as perioperative management is essential to prevent complications. Therefore, training in ophthalmology clinics where the patients who are treated with aforesaid drugs may increase the awareness on this issue.